Evidence map›Paper›PMID 30258276›Full record

ReviewCurrent genomics2018

Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview.

Nilabja Sikdar, Gourab Saha, Ashmita Dutta, Shibajyoti Ghosh, Shailesh V Shrikhande, Sudeep Banerjee

Open access · bronzeAbstract readReview
In one paragraph

Review in Current genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Indian journal of surgical oncology · 2024
    Article
  7. Expression Profile of KRAS and p16 in Periampullary Cancer.Indian journal of surgical oncology · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential.International journal of molecular sciences · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Characterization of novel genetic alterations in salivary gland secretory carcinoma.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Nilabja Sikdar1Human Genetics Unit, Indian Statistical Institute, 203 B.T. Road, Kolkata 700108, West Bengal, India; 2Medical College and Hospital, 88, College Street, Kolkata 700073, West Bengal, India; 3Tata Memorial Centre, Mumbai400012, India; 4Tata Medical Center, Newtown, Rajarhat, 700156, Kolkata, West Bengal, India.
Gourab Saha1Human Genetics Unit, Indian Statistical Institute, 203 B.T. Road, Kolkata 700108, West Bengal, India; 2Medical College and Hospital, 88, College Street, Kolkata 700073, West Bengal, India; 3Tata Memorial Centre, Mumbai400012, India; 4Tata Medical Center, Newtown, Rajarhat, 700156, Kolkata, West Bengal, India.
Ashmita Dutta1Human Genetics Unit, Indian Statistical Institute, 203 B.T. Road, Kolkata 700108, West Bengal, India; 2Medical College and Hospital, 88, College Street, Kolkata 700073, West Bengal, India; 3Tata Memorial Centre, Mumbai400012, India; 4Tata Medical Center, Newtown, Rajarhat, 700156, Kolkata, West Bengal, India.
Shibajyoti Ghosh1Human Genetics Unit, Indian Statistical Institute, 203 B.T. Road, Kolkata 700108, West Bengal, India; 2Medical College and Hospital, 88, College Street, Kolkata 700073, West Bengal, India; 3Tata Memorial Centre, Mumbai400012, India; 4Tata Medical Center, Newtown, Rajarhat, 700156, Kolkata, West Bengal, India.
Shailesh V Shrikhande1Human Genetics Unit, Indian Statistical Institute, 203 B.T. Road, Kolkata 700108, West Bengal, India; 2Medical College and Hospital, 88, College Street, Kolkata 700073, West Bengal, India; 3Tata Memorial Centre, Mumbai400012, India; 4Tata Medical Center, Newtown, Rajarhat, 700156, Kolkata, West Bengal, India.
Sudeep Banerjee1Human Genetics Unit, Indian Statistical Institute, 203 B.T. Road, Kolkata 700108, West Bengal, India; 2Medical College and Hospital, 88, College Street, Kolkata 700073, West Bengal, India; 3Tata Memorial Centre, Mumbai400012, India; 4Tata Medical Center, Newtown, Rajarhat, 700156, Kolkata, West Bengal, India.
Indian Statistical Institute · INMedical College and Hospital, Kolkata · INTata Medical Center · INTata Memorial Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic Ductal AdenoCarcinoma (PDAC) is one of the most lethal malignancies of all solid cancers. Precancerous lesions for PDAC include PanIN, IPMNs and MCNs. PDAC has a poor prognosis with a 5-year survival of approximately 6%. Whereas Periampulary AdenoCarcinoma (PAC) having four anatomic subtypes, pancreatic, Common Bile Duct (CBD), ampullary and duodenum shows relative better prognosis. The highest incidence of PDAC has been reported with black with respect to white population. Similarly, incidence rate of PAC also differs with different ethnic populations. Several lifestyle, environmental and occupational exposures including long-term diabetes, obesity, and smoking, have been linked to PDAC, however, for PAC the causal risk factors were poorly described. It is now clear that PDAC and PAC are a multi-stage process resulting from the accumulation of genomic alterations in the somatic DNA of normal cells as well as inherited mutations. Approximately 10% of PDAC have a familial inheritance. Germline mutations in CDKN2A, BRCA2, STK11, PALB2, PRSS1, etc., as well as certain syndromes have been well associated with predisposition to PDAC. KRAS, CDKN2A, TP53 and SMAD4 are the 4 "mountains" (high-frequency driver genes) which have been known to earliest somatic alterations for PDAC while relatively less frequent in PAC. Our understanding of the molecular carcinogenesis has improved in the last few years due to extensive research on PDAC which was not well explored in case of PAC. The genetic alterations that have been identified in PDAC and different subgroups of PAC are important implications for the development of genetic screening test, early diagnosis, and prognostic genetic markers. The present review will provide a brief overview of the incidence and prevalence of PDAC and PAC, mainly, increased risk in India, the several kinds of risk factors associated with the diseases as well as required genetic alterations for disease initiation and progression.

Indexed as

Familial pancreatic cancerHigh frequency mutationsLow frequency mutationsMolecular carcinogenesisPancreatic ductal adenocarcinomaPeriampullary adenocarcinoma

Identifiers

PMID30258276
PMCPMC6128383
OpenAlexW2789151443

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.